TY - JOUR T1 - Bronchial stump insufficiency after pneumonectomy in purulent-destructive diseases of lungs JF - European Respiratory Journal JO - Eur Respir J VL - 38 IS - Suppl 55 SP - p2432 AU - Shuhrat Hudaybergenov AU - Georgy Pahomov AU - Rustem Hayaliev AU - Ortikali Irisov AU - Otabek Eshonhodjaev AU - Sharif Rahimiy Y1 - 2011/09/01 UR - http://erj.ersjournals.com/content/38/Suppl_55/p2432.abstract N2 - As is well known, bronchial stump insufficiancy (BSI), bronchopleural fistulas (BPF) and connected with them empyema pleura are the main reasons of the reduction to efficiency of the surgical treatment of lung cancer, purulent-destructive diseases of lungs (PDDL) and other surgical pathology of thorax.Material and methods: Results of complex examination and treatment of 684 patients had comparative analysed, from which 575 (84,1%) patients underwent pneumonectomy (PE) on cause oncological pathology or PDDL, but 109 (15,9%) patients were treated on cause BPF after PE. The average age 56,4±4,1 years. The main group has formed 98 patients, admitted for 2006-2008 and undertaken designed tactics of the surgical treatment, founded on determination of the groups of the risk of the development BSI after PE.Results: The frequency BSI after PE depending on presence different factor among 87 patients with PDDL was apart considered. PE is on the right made in 25 (28,7%) patients, on the left in 62 (71,3%) patients. BSI after PE is revealled in 4 (16,0%) and 7 (11,3%) accordingly. PE on cause PDDL noted increasing of the frequency BSI from 10,5% to 12,6% (11 from 87 patients), and risk of the development of this complication, depending on side of the operations forms - 16,0% after right-side and 11,3% after leftside PE.Conclusions: In patients of oncological profile, which is planned PE, frequency of accompanying COPD forms 53,8% patient then in patients with PDDL this factor reaches 75,2%, in turn exacerbation COPD after performing PE noted in 48,8% and 63,6% patients accordingly, but risk of the development BSI on this background reaches 16,5% that requires including in the treatment nebulised therapy. ER -